Nuclear medicine techniques such as PET and SPECT provide functional and metabolic insights that enable early detection of complications and personalized management in patients with diabetes mellitus.
Nuclear medicine imaging provides valuable tools for the early detection, risk stratification, and individualized treatment of diabetes mellitus and its complications.
Diabetes mellitus (DM) is a chronic metabolic disease with complications such as cardiovascular disease, neuropathy, nephropathy, and infections. Early detection and personalized interventions are crucial for optimal management. Nuclear medicine techniques such as positron emission tomography and single-photon emission computed tomography play a key role in early diagnosis and assessment of DM complications, including diabetic foot infections, myocardial perfusion abnormalities, renal dysfunction, and peripheral arterial disease. This review also explores emerging radiotracers for β-cell imaging, glucose metabolism, and inflammation. These imaging tools enable a deeper understanding of diabetes pathophysiology and support precision medicine, enhancing early detection, risk stratification, and individualized treatment.
Amalo et al. (Thu,) conducted a review in Diabetes Mellitus. Nuclear medicine imaging was evaluated. Nuclear medicine techniques such as PET and SPECT provide functional and metabolic insights that enable early detection of complications and personalized management in patients with diabetes mellitus.